1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Greenbrook TMS Inc.
  6. Company
    GTMS   CA3937043097

GREENBROOK TMS INC.

(GTMS)
  Report
Delayed Quote. Delayed Toronto Stock Exchange - 05/24 03:50:27 pm
3.13 CAD   -3.69%
05/20GREENBROOK TMS : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS - Form 6-K
PU
05/16TRANSCRIPT : Greenbrook TMS Inc., Q1 2022 Earnings Call, May 16, 2022
CI
05/16Greenbrook TMS Says To Acquire Success TMS
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Greenbrook TMS Inc. is a provider of Transcranial Magnetic Stimulation (TMS) therapy, a non-invasive therapy for the treatment of major depressive disorder (MDD) and other mental health disorders, in the United States. It also offers treatment for obsessive compulsive disorder. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. It offers Spravato (esketamine nasal spray) at select TMS Centers to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. It operates a network of outpatient mental health service centers that specialize in TMS treatment across the United States. It owns and operates about 149 TMS Centers in the Commonwealth of Virginia and the States of Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts.

Number of employees : 430 people.
Sales per Business
20202021Delta
Outpatient Mental Health Service Centers57.85100%65.44100% +13.13%
CAD in Million
Sales per region
20202021Delta
United States57.85100%65.44100% +13.13%
CAD in Million
Managers
Name Title Age Since
William P. Leonard President, Chief Executive Officer & Director 56 2018
Erns Loubser Chief Financial Officer & Treasurer 37 2018
Geoffrey Grammer, Dr. Chief Medical Officer 50 2018
Diana Shi Senior Vice President-Operations - 2021
Iris Krug Vice President-Compliance & Privacy Officer - 2021
Euphia Hsu-Smith Chief Marketing Officer 49 2019
Megan Toufexis Medical Director, Florida - -
Kimberly Cress Regional Medical Director-Texas - -
Darlene Ifill-Taylor Regional Medical Dir.-Charlotte & North Carolina - -
Virginia Ashley Medical Director-Maryland - -
Members of the board
Name Title Age Since
Elias Vamvakas Chairman 62 2018
Brian P. Burke Independent Director 66 2018
Colleen R. Campbell Lead Independent Director 63 2018
Adrienne L. Graves, Dr. Independent Director 66 2018
Frank Tworecke Independent Director 74 2018
Adele C. Oliva Independent Director 55 2019
Sasha Cucuz Director 43 -
William P. Leonard President, Chief Executive Officer & Director 56 2018
Robert Higgins Director 38 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 17,801,885 9,237,540 51.9% 0 0.0% 51.9%
Shareholders
NameEquities%
Greybrook Health, Inc. 4,527,697 25.4%
1315 Capital LLC 2,294,648 12.9%
Masters Special Situations LLC 1,499,997 8.43%
William P. Leonard 832,500 4.68%
Roberto Drassinower 709,500 3.99%
Masters Capital Management LLC 700,000 3.93%
AWM Investment Co., Inc. 603,947 3.39%
Empire Life Investments, Inc. 435,857 2.45%
Royce & Associates LP 223,500 1.26%
Valentum Asset Management SGIIC SA 180,719 1.02%
Company contact information
Greenbrook TMS, Inc.
890 Yonge Street
7th floor
Toronto, ON M4W 3P4

Phone : +1.416.915.9100
Web : http://www.greenbrooktms.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Greenbrook TMS Inc.